Barriers and facilitators to deprescribing in primary care: a systematic review
AJ Doherty, P Boland, J Reed, AJ Clegg, AM Stephani… - BJGP open, 2020 - bjgpopen.org
Background Managing polypharmacy is a challenge for healthcare systems globally. It is
also a health inequality concern as it can expose some of the most vulnerable in society to …
also a health inequality concern as it can expose some of the most vulnerable in society to …
[HTML][HTML] Barriers and facilitators influencing medication-related CDSS acceptance according to clinicians: a systematic review
L Westerbeek, KJ Ploegmakers, GJ De Bruijn… - International Journal of …, 2021 - Elsevier
Background A medication-related Clinical Decision Support System (CDSS) is an
application that analyzes patient data to provide assistance in medication-related care …
application that analyzes patient data to provide assistance in medication-related care …
Use of an electronic decision support tool to reduce polypharmacy in elderly people with chronic diseases: cluster randomised controlled trial
Objective To evaluate the effects of a computerised decision support tool for comprehensive
drug review in elderly people with polypharmacy. Design Pragmatic, multicentre, cluster …
drug review in elderly people with polypharmacy. Design Pragmatic, multicentre, cluster …
Barriers and facilitators to the use of clinical decision support systems in primary care: a mixed-methods systematic review
PY Meunier, C Raynaud, E Guimaraes… - The Annals of Family …, 2023 - Annals Family Med
PURPOSE To identify and quantify the barriers and facilitators to the use of clinical decision
support systems (CDSSs) by primary care professionals (PCPs). METHODS A mixed …
support systems (CDSSs) by primary care professionals (PCPs). METHODS A mixed …
[HTML][HTML] Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis.
J Reeve, M Maden, R Hill, A Turk… - Health Technology …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Tackling problematic polypharmacy requires tailoring the use of medicines
to individual needs and circumstances. This may involve stopping medicines (deprescribing) …
to individual needs and circumstances. This may involve stopping medicines (deprescribing) …
[HTML][HTML] Factors associated with potentially inappropriate prescriptions and barriers to medicines optimisation among older adults in primary care settings: a systematic …
Z Xu, X Liang, Y Zhu, Y Lu, Y Ye, L Fang… - Family medicine and …, 2021 - ncbi.nlm.nih.gov
Factors associated with potentially inappropriate prescriptions and barriers to medicines
optimisation among older adults in primary care settings: a systematic review - PMC Back to …
optimisation among older adults in primary care settings: a systematic review - PMC Back to …
[HTML][HTML] Effect of a patient-centred deprescribing procedure in older multimorbid patients in Swiss primary care-A cluster-randomised clinical trial
S Zechmann, O Senn, F Valeri, S Essig, C Merlo… - BMC geriatrics, 2020 - Springer
Background Management of patients with polypharmacy is challenging, and evidence for
beneficial effects of deprescribing interventions is mixed. This study aimed to investigate …
beneficial effects of deprescribing interventions is mixed. This study aimed to investigate …
Deprescribing as a clinical improvement focus
TS Dharmarajan, H Choi, N Hossain… - Journal of the American …, 2020 - Elsevier
Objectives Polypharmacy is a concern in the practice of geriatrics because of consequences
such as adverse drug events and poorer quality of life. Deprescribing, a response to …
such as adverse drug events and poorer quality of life. Deprescribing, a response to …
Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study
Objective To explore the barriers/facilitators to deprescribing in primary care in England from
the perspectives of clinicians, patients living with frailty who reside at home, and their …
the perspectives of clinicians, patients living with frailty who reside at home, and their …
Barriers and facilitators to deprescribing of cardiovascular medications: a systematic review
Objective To synthesise the current knowledge on barriers and facilitators to deprescribing
cardiovascular medications (CVMs) at the levels of patients, informal caregivers and …
cardiovascular medications (CVMs) at the levels of patients, informal caregivers and …